Efficacy and tolerability of candesartan cilexetil in hypertensive, type II diabetic patients presenting with diabetic nephropathy (the 'decade' study)

被引：0
|
作者：
Mimran, A [1 ]
Nisse-Durgeat, S [1 ]
机构：
[1] Lapeyronie Hosp, Montpellier, France
来源：
JOURNAL OF HYPERTENSION | 2005年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S330 / S330
页数：1
相关论文
共 50 条
  • [41] Effects of candesartan on urinary alubumin and protein excretion in the diabetic patients with nephropathy
    Hayashi, I
    Asakawa, H
    Fukui, T
    Tokunaga, K
    DIABETES, 2002, 51 : A513 - A513
  • [42] Nitrosonifedipine prevents the progression of diabetic nephropathy in type II diabetic mice
    Fujii, Shoko
    Ishizawa, Keisuke
    Sakurada, Takumi
    Izawa-Ishizawa, Yuki
    Imanishi, Masaki
    Nuno, Asami
    Suzuki, Yuta
    Kihira, Yoshitaka
    Ikeda, Yasumasa
    Tomita, Shuhei
    Tsuchiya, Koichiro
    Tamaki, Toshiaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 92P - 92P
  • [43] Reduction of urinary connective tissue growth factor by losartan in hypertensive Type 10 diabetic patients with diabetic nephropathy
    Andersen, S
    Nieuwenhoven, FAV
    Rossing, P
    Tarnow, L
    Rossing, K
    Goldschmeding, R
    Parving, HH
    DIABETOLOGIA, 2004, 47 : A387 - A387
  • [44] Long term efficacy, safety, and tolerability of candesartan cilexetil added to hydrochlorothiazide in patients with severe systemic hypertension
    Oparii, S
    Michelson, EL
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 120A - 120A
  • [45] Quality of life, efficacy and tolerability following addition of nebivolol to non-diabetic and diabetic hypertensive patients:: The QoLaN (Quality of Life and Nebivolol) study
    Hermans, Michel P.
    De Coster, Olivier
    Godeaux, Lionel
    Huysse, Lieven
    De Borne, Philippe Van
    DIABETES, 2007, 56 : A567 - A567
  • [46] Evaluation of Diabetic Nephropathy and Associated Risk Factors in Type I and Type II Diabetic Patients at Badin, Sindh
    Sadiq, Ghulam
    Ali, Rizwan
    Samad, Abdul
    Naseem, Shehla
    Shaikh, Mohammad Zaman
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2022, 16 (01): : 111 - 112
  • [47] TYPE-II DIABETIC NEPHROPATHY IN PERSPECTIVE
    CHUKWUMA, C
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1995, 9 (01) : 55 - 67
  • [48] Serum adiponectin and progression of diabetic nephropathy in type 1 diabetic patients (The FinnDiane Study)
    Saraheimo, M. T.
    Forsblom, C.
    Thorn, L.
    Waden, J.
    Tolonen, N.
    Frystyk, J.
    Flyvbjerg, A.
    Groop, P.-H.
    DIABETOLOGIA, 2007, 50 : S114 - S115
  • [49] Progression of diabetic nephropathy in normotensive type 1 diabetic patients
    Jacobsen, P
    Rossing, K
    Tarnow, L
    Rossing, P
    Mallet, C
    Poirier, O
    Cambien, F
    Parving, HH
    KIDNEY INTERNATIONAL, 1999, 56 : S101 - S105
  • [50] Effectiveness of different angiotensin II receptor antagonists in hypertensive patients with type 2 diabetes mellitus and diabetic nephropathy
    Vatinian, S.
    Gurgenyan, S.
    Nikoghosyan, K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 266 - 266
12345